A Canadian Cohort Study of Cognitive Impairment and Related Dementias (ACCORD): Study Methods and Baseline ResultsFeldman H.a · Levy A.R.b · Hsiung G.-Y.a-c · Peters K.R.d · Donald A.e · Black S.E.f · Bouchard R.W.g · Gauthier S.G.h · Guzman D.A.i · Hogan D.B.j · Kertesz A.k · Rockwood K.l
Departments of aMedicine (Neurology), bHealth Care and Epidemiology, cMedical Genetics, dPsychology, and eStatistics, University of British Columbia, Vancouver, B.C.; fDepartment of Medicine (Neurology), University of Toronto, Toronto, Ont.; gDepartment of Medicine (Neurology), Laval University, Québec, Que.; hMcGill Center for Studies in Aging, McGill University, Montreal, Que.; iDepartment of Medicine (Neurology), University of Ottawa, Ottawa, Ont.; jDepartment of Medicine (Geriatrics), University of Calgary, Calgary, Alta.; kDepartment of Clinical Neurosciences, University of Western Ontario, London, Ont., and lDepartment of Medicine (Geriatrics, Neurology), Dalhousie University, Halifax, N.S., Canada
The overall objective of the Canadian Collaborative Cohort of Related Dementias (ACCORD) study is to describe the diagnostic distribution, natural history and treatment outcomes of individuals referred from the community to dementia clinics in Canada. Between 1997 and 1999, an inception cohort of 1,136 subjects entered into this longitudinal study. At the baseline assessment, 10.9% of the subjects were classified as ‘not cognitively impaired’ (NCI), 30.1% as ‘cognitively impaired not demented’ (CIND), and 59% as demented. A subclassification of CIND included amnestic 25.1%, vascular cognitive impairment 18.1%, psychiatric 17.2%, neurologic 7.3%, medical/toxic metabolic 3.5%, mixed 7.6% and not specified 19.0%. The percentage of the cohort referred with dementia increased progressively each decade, while the proportions of CIND and NCI decreased. Within the dementia group, Alzheimer’s disease accounted for 47.2% of the subjects, mixed dementias 33.7%, vascular dementia 8.7%, frontotemporal degenerations 5.4%, dementia with Lewy bodies 2.5%, and unclassifiable 1.8%. The ACCORD cohort will allow a detailed study of the longitudinal course of CIND, and the longer-term outcomes of both treated and untreated dementia subjects.
© 2003 S. Karger AG, Basel
Dr. Howard Feldman
Division of Neurology, Vancouver Hospital and Health Sciences Center
S192-2211 Wesbrook Mall
Vancouver, B.C. V6T 2B5 (Canada)
Tel. +1 604 822 7697, Fax +1 604 822 7703, E-Mail firstname.lastname@example.org
Number of Print Pages : 10
Number of Figures : 1, Number of Tables : 6, Number of References : 57
Founded 1982 by B.S. Schoenberg, continued by M. Alter (1989–1996)
Vol. 22, No. 5, Year 2003 (Cover Date: September-October 2003)
Journal Editor: G.C. Román, San Antonio, Tex.
ISSN: 0251–5350 (print), 1423–0208 (Online)
For additional information: http://www.karger.com/journals/ned